National Psychedelics Association
The National Psychedelics Association is a 501(c)(3) membership organization founded in 2019 that supports state-licensed Psychedelic-Assisted Care clinics, facilitators, and patients with compliance, banking, advocacy, and community services across Oregon, Colorado, and New Mexico.
- Company typePrivate
- Founded2019
- HeadquartersWashington, DC, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What National Psychedelics Association does
The National Psychedelics Association (NPA) is a Washington, DC-based non-profit 501(c)(3) organization founded in 2019 that serves as the central membership body for the state-regulated Psychedelic-Assisted Care (PAC) industry. It supports three distinct stakeholder groups — state-licensed healing centers, individual facilitators and practitioners, and patient participants — by delivering a bundled offering of merchant services, secure banking partnerships, technology tooling, regulatory compliance support, awareness campaigns, professional community access, and Continuing Professional Education credits. Pricing is not publicly disclosed, and the organization currently recruits on a state-by-state basis in jurisdictions where PAC is legal, with active footprints in Oregon, Colorado, and New Mexico.
The NPA operates a dual structure: the 501(c)(3) non-profit conducts federal and state advocacy (most notably a landmark DEA petition to reschedule psilocybin from Schedule I to Schedule II, federal litigation against the DEA, Right to Try advocacy, and state-level work on Oregon's Psilocybin Services Act and New Mexico's Medical Psilocybin Act), while a separate services arm, NPA Services, delivers the commercial member offerings. Revenue is generated primarily through recurring membership dues from facilitators and healing centers, supplemented by donations.
The organization is small, with 9 employees led by Founder and Board Chair Britton Rollins, Interim Executive Director Matthew Ettinger, COO Tom Byam-Cook, CIO Mathew Grimes, in-house counsel Jeff Silberman, and Special Advocacy Advisor Kathryn Tucker. It has assembled a clinical partner network of at least 9 named service centers, secured corporate sponsorships from Otsuka, Fluence, Omnicom Group, and Dr. Bronner's, and built a 900+ subscriber newsletter plus recurring virtual community sessions to engage the PAC ecosystem.
National Psychedelics Association firmographics
Firmographics- Name
- National Psychedelics Association
- Legal name
- National Psychedelics Association
- Website
- https://yournpa.org
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- The National Psychedelics Association is a 501(c)(3) membership organization founded in 2019 that supports state-licensed Psychedelic-Assisted Care clinics, facilitators, and patients with compliance, banking, advocacy, and community services across Oregon, Colorado, and New Mexico.
- Ownership category
- akta.pro rank
National Psychedelics Association industry classification
Industry- Product category
- Psychedelic-Assisted Care Industry Association Services
- NAICS
- Voluntary Health Organizations (813212), Human Rights Organizations (813311), Other Individual and Family Services (624190)
- SIC
- Services-Membership Organizations (8600), Services-Social Services (8300)
- akta.pro primary industry
- Rare Disease & Special Needs Support Organizations (BPAGACAM)
- akta.pro secondary industries
- Disability Services & Independent Living Support (BPAGACAG), Behavioral Health & Substance Use Public Health Programs (BPAIAJAK)
Keywords
Where National Psychedelics Association is headquartered
LocationHeadquarters
- HQ city
- Washington, DC
- HQ country
- United States
- HQ region
- North America
Markets served
National Psychedelics Association business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Dues: The NPA generates revenue through membership dues from state-licensed facilitators and healing centers in the Psychedelic-Assisted Care space. Members receive tailored services including merchant services, banking partnerships, technology solutions, regulatory compliance support, and awareness campaigns.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
National Psychedelics Association product offering
Product offeringCore offering
The NPA is a non-profit membership organization that sells membership services to state-licensed healing centers and facilitators in the Psychedelic-Assisted Care (PAC) industry. Member clinics receive tailored merchant services, secure banking partnerships, technology support, regulatory compliance assistance, and awareness campaigns; care professionals receive a professional community, Continuing Professional Education credits, and compliance solutions. The organization also sells advocacy services spanning psilocybin rescheduling, Right to Try access, homebound Oregonian access litigation, and advisory support for New Mexico's Medical Psilocybin Act.
Product overview
The National Psychedelics Association operates as a membership-based organization providing a suite of services to the Psychedelic-Assisted Care (PAC) industry. The core offerings include membership services for state-licensed healing centers (providing merchant services, banking partnerships, technology support, and regulatory compliance) and for care professionals (providing community access, CPE credits, and compliance solutions). The organization also provides advocacy services focused on federal psilocybin rescheduling via DEA petition and federal litigation, Right to Try access advocacy, state-level advocacy for homebound access in Oregon, and advisory support for New Mexico's Medical Psilocybin Act. Community engagement is supported through virtual sessions that share infrastructure best practices across states implementing legal psychedelic care.
Differentiator
Problem solved
Functional benefit
Products and services
- Membership Services for Member Clinics Membership offering for state-licensed healing centers and service centers in Psychedelic-Assisted Care, providing tailored merchant services, secure banking partnerships, technology streamlining operations, regulatory compliance support, and awareness campaigns.
- Membership Services for Care Professionals
- Psilocybin Rescheduling Advocacy
Companies that use National Psychedelics Association
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles2 records
National Psychedelics Association technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
National Psychedelics Association partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered minor and core.
- OtsukaminorOtsuka is listed as a sponsor of the National Psychedelics Association, appearing in the sponsors section of the website alongside other industry partners.
- FluenceminorFluence is listed as a sponsor of the National Psychedelics Association, appearing in the sponsors section alongside other industry partners.
- Omnicom GroupminorOmnicom Group is listed as a sponsor of the National Psychedelics Association, appearing in the sponsors section alongside other industry partners.
- PNW Integrative CentercorePNW Integrative Center is identified as a clinical partner working with the NPA. The center's founder, Mike Averill, has provided a testimonial about the value of NPA's support services for building a reliable PAC service.
- Drop ThesiscoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- Cora CentercoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- Oregon Psychedelic SolutionscoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- Experience OnwardcoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- ChariotcoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- The Sacred MushroomcoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- Vital ResetcoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- Omnia GroupcoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- EPICcoreListed as a clinical partner of the NPA, appearing alongside other service center partners on the team page.
- Dr. Bronner'sminorDavid Bronner, CEO of Dr. Bronner's, organized and hosted a demonstration at the DEA headquarters in support of psilocybin access for terminally ill patients. Dr. Bronner is described as a well-known champion of opening access to psychedelics.
- Psychedelics TodayminorPsychedelics Today has featured NPA's Special Advocacy Advisor Kathryn Tucker on multiple podcast episodes discussing the legal battle for psilocybin access, including the Advocacy Spotlight Initiative and other interviews about right-to-try and rescheduling efforts.
Scale indicators3 records
Recent moves7 records
Expansion highlights6 records
National Psychedelics Association competitors and assessment
Company assessmentBroad incumbents
- Drug Policy Alliance: Leading national nonprofit advocating for drug policy reform including psychedelic decriminalization. Shares the federal advocacy and coalition-building model but operates at broader drug-policy scale rather than focusing specifically on PAC industry infrastructure.
- NORML (National Organization for the Reform of Marijuana Laws): Established nonprofit advocating for cannabis legalization and policy reform. Highly comparable operational model (federal advocacy, state-level chapters, membership dues, litigation) and a useful precedent for what a mature psychedelic advocacy organization could evolve into.
Others
- Compass Pathways: Publicly listed psychedelic therapy company developing psilocybin treatment. Not a direct peer (for-profit operator vs. association), but a key industry stakeholder whose regulatory progress directly affects NPA member clinics and rescheduling outcomes.
Emerging players
- Third Wave: Educational platform and community serving psychedelic-curious consumers and practitioners. Comparable audience overlap but distinct business model (consumer-facing education vs. B2B membership/advocacy for licensed operators).
- Psychedelic Alpha: Information service providing business intelligence on the psychedelic industry. Adjacent rather than directly competitive — both serve the PAC ecosystem with information, though Psychedelic Alpha is research/media-focused rather than membership-based advocacy.
- Reason for Hope: Nonprofit focused on psychedelic therapy access and clinician training. Comparable mission and nonprofit structure, with overlapping focus on practitioner education and regulatory engagement, though smaller scale.
Direct peers
- MAPS (Multidisciplinary Association for Psychedelic Studies): Long-established 501(c)(3) nonprofit advocating for psychedelic research, therapy access, and policy reform. Most direct peer — both organizations operate as psychedelic-focused membership/advocacy nonprofits with overlapping federal policy goals (including rescheduling efforts and Right-to-Try access).
- Beckley Foundation: UK-based nonprofit conducting and funding psychedelic research and drug policy reform. Comparable as an advocacy-led psychedelic organization, though operating regionally (UK/EU) rather than focused on US state-level PAC infrastructure.
- Usona Institute: Nonprofit medical research organization sponsoring psilocybin clinical trials. Comparable as a psychedelic-focused 501(c)(3) with advocacy and clinical infrastructure goals, including FDA-aligned drug development that intersects with rescheduling efforts.
- Chacruna Institute: Nonprofit fostering psychedelic research, education, and cultural understanding. Comparable as a membership/community-oriented psychedelic nonprofit with advocacy and convening functions, though focused more on anthropological and Indigenous-knowledge dimensions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
National Psychedelics Association social profiles
Digital presenceNational Psychedelics Association financial estimates
Financial estimateRevenue estimate
Valuation estimate
National Psychedelics Association leadership team
Management profileNumber of profiles
Profiles10 records
National Psychedelics Association subsidiaries and ownership
Company hierarchySubsidiaries1 record
National Psychedelics Association funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
National Psychedelics Association M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about National Psychedelics Association
What does National Psychedelics Association do?
The NPA is a non-profit membership organization that sells membership services to state-licensed healing centers and facilitators in the Psychedelic-Assisted Care (PAC) industry. Member clinics receive tailored merchant services, secure banking partnerships, technology support, regulatory compliance assistance, and awareness campaigns; care professionals receive a professional community, Continuing Professional Education credits, and compliance solutions. The organization also sells advocacy services spanning psilocybin rescheduling, Right to Try access, homebound Oregonian access litigation, and advisory support for New Mexico's Medical Psilocybin Act.
Is National Psychedelics Association a public or private company?
National Psychedelics Association is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was National Psychedelics Association founded?
National Psychedelics Association was founded in 2019. It employs 1 to 10 people.
Where is National Psychedelics Association based?
National Psychedelics Association is headquartered in Washington, DC, United States, in the North America region.
How does National Psychedelics Association make money?
One revenue line is on record: membership Dues.
Who are National Psychedelics Association's main competitors?
Broad incumbents on record are Drug Policy Alliance and NORML (National Organization for the Reform of Marijuana Laws). Compass Pathways is listed as an others. Emerging players are Third Wave, Psychedelic Alpha and Reason for Hope. Direct peers are MAPS (Multidisciplinary Association for Psychedelic Studies), Beckley Foundation, Usona Institute and Chacruna Institute.
Does National Psychedelics Association have an API?
No public API is recorded for National Psychedelics Association.
What industry is National Psychedelics Association in?
National Psychedelics Association's product category is Psychedelic-Assisted Care Industry Association Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of BPAGACAG, Disability Services & Independent Living Support. Its NAICS code is 813212 and its SIC code is 8600.